{"transactions":[{"id":778203,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":1108,"price":33.38,"value":36985.04,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Represents sales of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778202,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":300,"price":32.2467,"value":9674.01,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Represents VWAP of sales of 300 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $32.0625 to $32.615."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778201,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":4423,"price":31.3843,"value":138812.7589,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Represents VWAP of sales of 4,423 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $30.9852 to $31.813."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778200,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":205,"price":29.7146,"value":6091.493,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Represents VWAP of sales of 205 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $29.695 to $30.50."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778199,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":2115,"price":28.9417,"value":61211.6955,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents VWAP of sales of 2,115 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $28.5071 to $29.3167."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778198,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"purchase","planned":false,"acquired":true,"shares":1108,"price":33.38,"value":36985.04,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents VWAP of purchases of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778197,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-06","kind":"sale","planned":false,"acquired":false,"shares":45,"price":31.9628,"value":1438.326,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents VWAP of sales of 45 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $31.80 to $32.17."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":141029,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778196,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-06","kind":"sale","planned":false,"acquired":false,"shares":1214,"price":31.0227,"value":37661.5578,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents VWAP of sales of 1,214 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $30.64 to $31.345."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":141029,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778195,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-06","kind":"purchase","planned":false,"acquired":true,"shares":1104,"price":31.02,"value":34246.08,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents purchases of 1,104 shares of the Company's Common Stock on April 6, 2026 at $31.02 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":141029,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778194,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":1134,"price":34.8007,"value":39463.9938,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents VWAP of sales of 1,134 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $34.40 to $35.25."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778193,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":374,"price":33.347,"value":12471.778,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents VWAP of sales of 374 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.23 to $33.45."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778192,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":1794,"price":32.6041,"value":58491.7554,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents VWAP of sales of 1,794 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $32.22 to $33.1251."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778191,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":1265,"price":31.751,"value":40165.015,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents VWAP of sales of 1,265 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $31.21 to $32.15."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778190,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":3099,"price":30.8638,"value":95646.9162,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents VWAP of sales of 3,099 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $30.1332 to $31.1212."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778189,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"purchase","planned":false,"acquired":true,"shares":701,"price":35.5472,"value":24918.5872,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents VWAP of purchases of 701 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $35.4481 to $35.91."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778188,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"purchase","planned":false,"acquired":true,"shares":1276,"price":34.7524,"value":44344.0624,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents VWAP of purchases of 1,276 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.97 to $34.90."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778187,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"purchase","planned":false,"acquired":true,"shares":26,"price":33.4704,"value":870.2304,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price (\"VWAP\") of purchases of 26 shares of common stock (\"Common Stock\"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the \"Company\") on April 2, 2026 at prices ranging from $32.90 to $33.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting persons will provide full information regarding the number of shares purchased or sold by the reporting person at each separate price within each range represented by a VWAP disclosed herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778220,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-04-01","kind":"sale","planned":false,"acquired":false,"shares":46,"price":34.7464,"value":1598.3344,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Represents VWAP of sales of 46 shares of the Company's Common Stock on April 1, 2026 at prices ranging from $34.5271 to $35.3850."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":147731,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778219,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-04-01","kind":"sale","planned":false,"acquired":false,"shares":1104,"price":31.52,"value":34798.08,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Represents sales of 1,104 shares of the Company's Common Stock on April 1, 2026 at $31.52 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":147731,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778218,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-04-01","kind":"purchase","planned":false,"acquired":true,"shares":3401,"price":35.4554,"value":120583.8154,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Represents VWAP of purchases of 3,401 shares of the Company's Common Stock on April 1, 2026 at prices ranging from $35.06 to $35.90."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":147731,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778217,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-04-01","kind":"purchase","planned":false,"acquired":true,"shares":1613,"price":34.5863,"value":55787.7019,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Represents VWAP of purchases of 1,613 shares of the Company's Common Stock on April 1, 2026 at prices ranging from $34.04 to $34.98."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":147731,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778216,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-04-01","kind":"purchase","planned":false,"acquired":true,"shares":1161,"price":31.5309,"value":36607.3749,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents VWAP of purchases of 1,161 shares of the Company's Common Stock on April 1, 2026 at prices ranging from $31.52 to $32.50."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":147731,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778215,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":87,"price":31.52,"value":2742.24,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents sales of 87 shares of the Company's Common Stock on March 31, 2026 at $31.52 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778214,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":5,"price":28.405,"value":142.025,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents sales of 5 shares of the Company's Common Stock on March 31, 2026 at $28.4050 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778213,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":57,"price":27.1147,"value":1545.5379,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents sales of 57 shares of the Company's Common Stock on March 31, 2026 at $27.1147 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778212,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":1251,"price":25.1676,"value":31484.6676,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents VWAP of sales of 1,251 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $25.13 to $25.45."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778211,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":191,"price":24.2843,"value":4638.3013,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents VWAP of sales of 191 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $23.91 to $24.6089."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778210,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":411,"price":32.5962,"value":13397.0382,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents VWAP of purchases of 411 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $32.4343 to $32.91."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778209,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1957,"price":31.4512,"value":61549.9984,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents VWAP of purchases of 1,957 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $31.215 to $31.17."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778208,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":186,"price":30.4754,"value":5668.4244,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents VWAP of purchases of 186 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $30.1693 to $30.73."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778207,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":17,"price":27.7838,"value":472.3246,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents VWAP of purchases of 17 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $27.525 to $28.405."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778206,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1048,"price":26.7259,"value":28008.7432,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents VWAP of purchases of 1,048 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $26.2587 to $27.1994."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778205,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1770,"price":25.3209,"value":44817.993,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents VWAP of purchases of 1,770 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $25.13 to $26.12."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778204,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":616,"price":24.6857,"value":15206.3912,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price (\"VWAP\") of purchases of 616 shares of common stock (\"Common Stock\"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the \"Company\") on March 31, 2026 at prices ranging from $23.91 to $24.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting persons will provide full information regarding the number of shares purchased or sold by the reporting person at each separate price within each range represented by a VWAP disclosed herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778186,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"sale","planned":false,"acquired":false,"shares":370,"price":27.68,"value":10241.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Represents sales of 370 shares of the Company's Common Stock on March 30, 2026 at $27.68 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778185,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"sale","planned":false,"acquired":false,"shares":518,"price":25.8501,"value":13390.3518,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Represents VWAP of sales of 518 shares of the Company's Common Stock on March 30, 2026 at prices ranging from $25.13 to $26.0734."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778184,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":370,"price":27.68,"value":10241.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Represents purchases of 370 shares of the Company's Common Stock on March 30, 2026 at $27.68 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778183,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":1176,"price":26.7,"value":31399.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Represents VWAP of purchases of 1,176 shares of the Company's Common Stock on March 30, 2026 at prices ranging from $26.50 to $26.90."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778182,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":4995,"price":25.99,"value":129820.05,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents VWAP of purchases of 4,995 shares of the Company's Common Stock on March 30, 2026 at prices ranging from $25.50 to $26.48."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778181,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":2992,"price":25.0784,"value":75034.5728,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents VWAP of purchases of 2,992 shares of the Company's Common Stock on March 30, 2026 at prices ranging from $24.495 to $25.1856."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778180,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-27","kind":"sale","planned":false,"acquired":false,"shares":36,"price":27.369,"value":985.284,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents VWAP of sales of 36 shares of the Company's Common Stock on March 27, 2026 at prices ranging from $27.2322 to $27.68."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":142360,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778179,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-27","kind":"sale","planned":false,"acquired":false,"shares":469,"price":26.7652,"value":12552.8788,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents VWAP of sales of 469 shares of the Company's Common Stock on March 27, 2026 at prices ranging from $26.21 to $26.95."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":142360,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778178,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-27","kind":"purchase","planned":false,"acquired":true,"shares":294,"price":28.1301,"value":8270.2494,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents VWAP of purchases of 294 shares of the Company's Common Stock on March 27, 2026 at prices ranging from $28.10 to $28.60."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":142360,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778177,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-27","kind":"purchase","planned":false,"acquired":true,"shares":4384,"price":27.2826,"value":119606.9184,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents VWAP of purchases of 4,384 shares of the Company's Common Stock on March 27, 2026 at prices ranging from $26.9750 to $27.68."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":142360,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778176,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-27","kind":"purchase","planned":false,"acquired":true,"shares":10643,"price":26.2933,"value":279839.5919,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents VWAP of purchases of 10,643 shares of the Company's Common Stock on March 27, 2026 at prices ranging from $25.9197 to $26.88."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":142360,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778175,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":1274,"price":28.6882,"value":36548.7668,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents VWAP of sales of 1,274 shares of the Company's Common Stock on March 26, 2026 at prices ranging from $28.07 to $28.7651."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778174,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":583,"price":26.8797,"value":15670.8651,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents VWAP of sales of 583 shares of the Company's Common Stock on March 26, 2026 at prices ranging from $26.68 to $27.4650."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778173,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":1025,"price":29.9788,"value":30728.27,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents VWAP of purchases of 1,025 shares of the Company's Common Stock on March 26, 2026 at prices ranging from $29.79 to $30.105."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778172,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":2601,"price":28.8539,"value":75048.9939,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents VWAP of purchases of 2,601 shares of the Company's Common Stock on March 26, 2026 at prices ranging from $28.7072 to $29.51."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778171,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":1327,"price":27.9467,"value":37085.2709,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents VWAP of purchases of 1,327 shares of the Company's Common Stock on March 26, 2026 at prices ranging from $27.70 to $28.4163."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778170,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":778,"price":27.2267,"value":21182.3726,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price (\"VWAP\") of purchases of 778 shares of common stock (\"Common Stock\"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the \"Company\") on March 26, 2026 at prices ranging from $26.66 to $27.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting persons will provide full information regarding the number of shares purchased or sold by the reporting person at each separate price within each range represented by a VWAP disclosed herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":1887432,"issuer":{"id":8076,"kind":"organization","name":"CXApp Inc."},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Footnote 3"}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":2,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Footnote 3"}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":3,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Footnote 3"}},{"id":113367,"kind":"organization","name":"ICS OPPORTUNITIES, LTD.","position":4,"cik":"0001487118","reported_name":"ICS OPPORTUNITIES, LTD.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-05-18T20:37:36.000Z","date":"2022-12-28","kind":"other","planned":false,"acquired":false,"shares":175000,"price":10.1246,"value":1771805.0,"ownership":{"direct":false,"nature":"See Footnote 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"ICS Opportunities, Ltd. tendered and redeemed 175,000 shares of the Class A common stock, par value $0.0001 per share (\"Class A Common Stock\") of KINS Technology Group Inc. for $10.124613 per share in connection with the Issuer's special meeting of stockholders held on December 9, 2022. CXApp Inc. is the successor to KINS Technology Group Inc."},{"field":"shares","element":"transactionShares","label":"F3","text":"The securities disclosed herein as held by ICS Opportunities, Ltd. and other affiliates of Millennium Management LLC are subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of such securities. Each reporting person disclaims beneficial ownership of the Class A Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As of May 17, 2023, ICS Opportunities, Ltd. held 2 shares of the Issuer's Class A Common Stock and other affiliates of Millennium Management LLC held 336 shares of the Issuer's Class A Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The securities disclosed herein as held by ICS Opportunities, Ltd. and other affiliates of Millennium Management LLC are subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of such securities. Each reporting person disclaims beneficial ownership of the Class A Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities disclosed herein as held by ICS Opportunities, Ltd. and other affiliates of Millennium Management LLC are subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of such securities. Each reporting person disclaims beneficial ownership of the Class A Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":338,"source":{"system":"sec-edgar","filing":"0001062993-23-011633","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017456/000106299323011633/form4.xml","form_type":"4"}},{"id":2463019,"issuer":{"id":8522,"kind":"organization","name":"FiscalNote Holdings, Inc.","symbol":"NOTE"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false,"other_text":"May be deemed a group member."}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":2,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":3,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares, par value $0.0001 per share","published_at":"2021-12-21T22:18:00.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":300000,"price":9.87,"value":2961000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This Form 4 reflects the purchases and sales of the Issuer's Class A Ordinary Shares made by ICS Opportunities II."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"As of the close of business on December 17, 2021, the reporting persons beneficially owned an aggregate of 1,575,000 Class A ordinary shares, par value $0.0001 per share (\"Class A Ordinary Shares\") of Duddell Street Acquisition Corp., a Cayman Islands exempted company (the \"Issuer\"). Specifically, (i) Integrated Core Strategies (US) LLC, a Delaware limited liability company (\"Integrated Core Strategies\"), beneficially owned 1,000,000 of the Issuer's Class A Ordinary Shares, (ii) ICS Opportunities, Ltd., an exempted company organized under the laws of the Cayman Islands (\"ICS Opportunities\"), beneficially owned 525,000 of the Issuer's Class A Ordinary Shares and (iii) ICS Opportunities II LLC, a Cayman Islands limited liability company (\"ICS Opportunities II\"), beneficially owned 50,000 of the Issuer's Class A Ordinary Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Millennium International Management LP, a Delaware limited partnership (\"Millennium International Management\"), is the investment manager to ICS Opportunities and ICS Opportunities II and may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Millennium Management LLC, a Delaware limited liability company (\"Millennium Management\"), is the general partner of the managing member of Integrated Core Strategies and may be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Management is also the general partner of the 100% owner of ICS Opportunities and ICS Opportunities II and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Millennium Group Management LLC, a Delaware limited liability company (\"Millennium Group Management\"), is the managing member of Millennium Management and may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Group Management is also the general partner of Millennium International Management and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The managing member of Millennium Group Management is a trust of which Israel A. Englander, a United States citizen (\"Mr. Englander\"), currently serves as the sole voting trustee. Therefore, Mr. Englander may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies, ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The foregoing should not be construed in and of itself as an admission by Millennium International Management, Millennium Management, Millennium Group Management or Mr. Englander as to beneficial ownership of the securities owned by Integrated Core Strategies, ICS Opportunities or ICS Opportunities II, as the case may be. Each reporting person disclaims beneficial ownership of the Class A Ordinary Shares disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":1575000,"source":{"system":"sec-edgar","filing":"0001273087-21-000026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1017456/000127308721000026/edgar.xml","form_type":"4"}},{"id":2463018,"issuer":{"id":8522,"kind":"organization","name":"FiscalNote Holdings, Inc.","symbol":"NOTE"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false,"other_text":"May be deemed a group member."}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":2,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":3,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares, par value $0.0001 per share","published_at":"2021-12-21T22:18:00.000Z","date":"2021-11-12","kind":"purchase","acquired":true,"shares":30681,"price":9.916,"value":304232.796,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This Form 4 reflects the purchases and sales of the Issuer's Class A Ordinary Shares made by ICS Opportunities II."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This represents the volume-weighted average price of purchases at prices ranging from $9.91 to $9.92, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, the reporting persons will provide details regarding the number of shares purchased by the reporting person at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Millennium International Management LP, a Delaware limited partnership (\"Millennium International Management\"), is the investment manager to ICS Opportunities and ICS Opportunities II and may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Millennium Management LLC, a Delaware limited liability company (\"Millennium Management\"), is the general partner of the managing member of Integrated Core Strategies and may be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Management is also the general partner of the 100% owner of ICS Opportunities and ICS Opportunities II and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Millennium Group Management LLC, a Delaware limited liability company (\"Millennium Group Management\"), is the managing member of Millennium Management and may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Group Management is also the general partner of Millennium International Management and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The managing member of Millennium Group Management is a trust of which Israel A. Englander, a United States citizen (\"Mr. Englander\"), currently serves as the sole voting trustee. Therefore, Mr. Englander may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies, ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The foregoing should not be construed in and of itself as an admission by Millennium International Management, Millennium Management, Millennium Group Management or Mr. Englander as to beneficial ownership of the securities owned by Integrated Core Strategies, ICS Opportunities or ICS Opportunities II, as the case may be. Each reporting person disclaims beneficial ownership of the Class A Ordinary Shares disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":1875000,"source":{"system":"sec-edgar","filing":"0001273087-21-000026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1017456/000127308721000026/edgar.xml","form_type":"4"}},{"id":2463017,"issuer":{"id":8522,"kind":"organization","name":"FiscalNote Holdings, Inc.","symbol":"NOTE"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false,"other_text":"May be deemed a group member."}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":2,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":3,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares, par value $0.0001 per share","published_at":"2021-12-21T22:18:00.000Z","date":"2021-11-08","kind":"purchase","acquired":true,"shares":54773,"price":9.915,"value":543074.295,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This Form 4 reflects the purchases and sales of the Issuer's Class A Ordinary Shares made by ICS Opportunities II."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This represents the volume-weighted average price of purchases at prices ranging from $9.915 to $9.92, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, the reporting persons will provide details regarding the number of shares purchased by the reporting person at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Millennium International Management LP, a Delaware limited partnership (\"Millennium International Management\"), is the investment manager to ICS Opportunities and ICS Opportunities II and may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Millennium Management LLC, a Delaware limited liability company (\"Millennium Management\"), is the general partner of the managing member of Integrated Core Strategies and may be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Management is also the general partner of the 100% owner of ICS Opportunities and ICS Opportunities II and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Millennium Group Management LLC, a Delaware limited liability company (\"Millennium Group Management\"), is the managing member of Millennium Management and may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Group Management is also the general partner of Millennium International Management and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The managing member of Millennium Group Management is a trust of which Israel A. Englander, a United States citizen (\"Mr. Englander\"), currently serves as the sole voting trustee. Therefore, Mr. Englander may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies, ICS Opportunities and ICS Opportunities II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The foregoing should not be construed in and of itself as an admission by Millennium International Management, Millennium Management, Millennium Group Management or Mr. Englander as to beneficial ownership of the securities owned by Integrated Core Strategies, ICS Opportunities or ICS Opportunities II, as the case may be. Each reporting person disclaims beneficial ownership of the Class A Ordinary Shares disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":1844319,"source":{"system":"sec-edgar","filing":"0001273087-21-000026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017456/000127308721000026/edgar.xml","form_type":"4"}},{"id":3122546,"issuer":{"id":83670,"kind":"organization","name":"BM Technologies, Inc.","symbol":"BMTX"},"owners":[{"id":148695,"kind":"organization","name":"INTEGRATED CORE STRATEGIES (US) LLC","position":1,"cik":"0001319244","reported_name":"INTEGRATED CORE STRATEGIES (US) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":2,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2020-06-04T20:36:01.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":21,"price":10.55,"value":221.55,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"As of the close of business on June 3, 2020, Integrated Core Strategies (US) LLC, a Delaware limited liability company (\"Integrated Core Strategies\"), beneficially owned 290,000 shares of the Issuer's Class A common stock, par value $0.0001 per share (\"Class A Common Stock\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Millennium Management LLC, a Delaware limited liability company (\"Millennium Management\"), is the general partner of the managing member of Integrated Core Strategies and may be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Millennium Group Management LLC, a Delaware limited liability company (\"Millennium Group Management\"), is the managing member of Millennium Management and may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The managing member of Millennium Group Management is a trust of which Israel A. Englander, a United States citizen (\"Mr. Englander\"), currently serves as the sole voting trustee. Therefore, Mr. Englander may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The foregoing should not be construed in and of itself as an admission by Millennium Management, Millennium Group Management or Mr. Englander as to beneficial ownership of the securities owned by Integrated Core Strategies."}],"balance_after":290000,"source":{"system":"sec-edgar","filing":"0001319244-20-000091","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1017456/000131924420000091/edgar.xml","form_type":"4"}},{"id":3122545,"issuer":{"id":83670,"kind":"organization","name":"BM Technologies, Inc.","symbol":"BMTX"},"owners":[{"id":148695,"kind":"organization","name":"INTEGRATED CORE STRATEGIES (US) LLC","position":1,"cik":"0001319244","reported_name":"INTEGRATED CORE STRATEGIES (US) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":2,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2020-06-04T20:36:01.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":189,"price":10.52,"value":1988.28,"ownership":{"direct":true},"balance_after":290021,"source":{"system":"sec-edgar","filing":"0001319244-20-000091","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1017456/000131924420000091/edgar.xml","form_type":"4"}},{"id":3122544,"issuer":{"id":83670,"kind":"organization","name":"BM Technologies, Inc.","symbol":"BMTX"},"owners":[{"id":148695,"kind":"organization","name":"INTEGRATED CORE STRATEGIES (US) LLC","position":1,"cik":"0001319244","reported_name":"INTEGRATED CORE STRATEGIES (US) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":2,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2020-06-04T20:36:01.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":91,"price":10.5,"value":955.5,"ownership":{"direct":true},"balance_after":290210,"source":{"system":"sec-edgar","filing":"0001319244-20-000091","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1017456/000131924420000091/edgar.xml","form_type":"4"}},{"id":3122543,"issuer":{"id":83670,"kind":"organization","name":"BM Technologies, Inc.","symbol":"BMTX"},"owners":[{"id":148695,"kind":"organization","name":"INTEGRATED CORE STRATEGIES (US) LLC","position":1,"cik":"0001319244","reported_name":"INTEGRATED CORE STRATEGIES (US) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":2,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"May be deemed a group member."}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2020-06-04T20:36:01.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":209699,"price":10.45,"value":2191354.55,"ownership":{"direct":true},"balance_after":290301,"source":{"system":"sec-edgar","filing":"0001319244-20-000091","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017456/000131924420000091/edgar.xml","form_type":"4"}}]}